Keywords
drug-reactions
exantema
eosinophilia
systemic symptoms
How to Cite
Abstract
DRESS syndrome (Drug rash with Eosinophilia and Systemic Symptoms) is an idiosyncratic reaction (type B), characterized by peripheral eosinophilia and systemic symptoms, such as fever, rash, lymphadenopathy, hepatitis, atypical lymphocytes and elevation of liver enzymes at least twice its normal level or increase of alanine amino transferase (ALT) >100 U/L. Its incidence is of 1/1,000 to 10,000 exposures and its mortality is of 10%-20%. Treatment is based on steroids and on the suspension of the suspect drug. This paper reports the cases of six patients with DRESS syndrome attended at Centro Medico Nacional Siglo XXI, Mexico City, from September 2012 to September 2013, which accounted for 12.5% of patients attended with adverse reactions to drugs.
References
Eosinophilia and Systemic Symptoms (DRESS): A complex interaction of drugs, viruses and the immune system. IMAJ 2012;14:577-582.
Magliano J, Álvarez M, et al. Síndrome DRESS por carbamazepina. Arch Pediatr Urug 2009;80:291-295.
Scherer K, Bircher A. Danger signs in drug hypersensitivity. Med Clin N Am 2010;94:681-689.
Criado P, Jardim RF, Giuli C, et al. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Drug-Induced Hypersensivity Syndrome (DIHS): a review of current concepts. An Bras Dermatol 2012;87:435-449.
Warrington R, Silviu-Dan F. Drug allergy. Allergy Asthma Clin Immunol 2011;7:S10.
Kano Y, Shiohara T. The variable clinical picture of Drug- Induced Hypersensitivity Syndrome/Drug Rash with Eosinophilia and systemic symptoms in relation to the eliciting drug. Immunol Allergy Clin N Am 2009;29:481-501.
Lee J, Park H, Heo J, et al. Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome induced by celecoxib and anti-tuberculosis drugs. J Korean Med Sci 2008;23:521-525.
Lens S, Crespo G, Carrión J, et al. Severe acute hepatitis in the syndrome. Ann Hepatol 2010;9:198-201.
Michel F, Navellou J, Ferraud D, et al. DRESS syndrome in a patient on sulfasalazine for rheumatoid arthritis. Joint Bone Spine 2005;72:82-85.
Jeung Y, Lee J, Oh M, et al. Comparison of the causes and clinical features of drug rash with eosinophilia and systemic symptoms and Stevens-Johnson Syndrome. Allergy Asthma Immunol Res 2010;2:123-126.
Felgueiras P, Guerreiro E, Pereira E, López R. Síndrome de DRESS. Galicia Clin 2011;72:185-187.
Gentile I, Talamo M, Borgia G. Is the drug-induced hypersensitivity syndrome (DIHS) due to human herpesvirus 6 infection or to allergy-mediated viral reactivation? Report of a case and literature review. BMC infection Diseases 2010;10:2-5.
Saida S, Yoshida A, Tanaka R, et al. A case of Drug-Induced Hypersensitivity Syndrome-like symptoms following HHV-6 encephalopathy. Allergol Int 2010;59:83-86.
Shiohara T, Inaoka M, Kano Y. Drug-Induced Hypersensitivity Syndrome (DIHS): A reaction induced by complex interplay among herpesviruses and antiviral and antidrug immune responses. Allergol Int 2006;55:1-8.
Jeffrey D, Steven J. Drug reaction with eosinophilia and systemic symptoms syndrome in a patient taking phenytoin and levetiracetam: a case report. J Med Case Reports 2013;7: 1-5.
Roujeau JC, Allanore L, Liss Y, et al. Severe Cutaneous Adverse Reactions to Drugs (SCAR): Definitions, diagnostic criteria, genetic predisposition. Dermatol Sinica 2009:203-209.
Cervigón I, Sandín S, Pérez C, et al. Síndrome de DRESS (Drug Rash with Eosinophilia and Systemic Symptoms) por sulfonamidas. Med Cutan Iber Lat Am 2006;34:120-126.
Santiago F, Goncalo M, Vieira R, et al. Epicutaneous patch testing in drug hypersensivitiy syndrome (DRESS). Contact Dermatitis 2010:62;47-53.
Tas S, Simonart T. Management of Drug Rash with Eosinophilia and Systemic Symptoms (DRESS syndrome) An update. Dermatology 2003;206:353-356.
Walsh S, Creamer D. Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking. Clinical Dermatology 2010;36:6-11.
Kocaoglu C, Cilasun C, Solak E, et al. Successful treatment of antiepileptic drug-induced DRESS syndrome with pulse methylprednisolone. Case Reports Pediatrics 2013:1-5.
Meik S, Arias M, Fernández L, et al. Síndrome de hipersensibilidad a anticonvulsivantes (síndrome de DRESS): comunicación de 4 casos. Dermatol Argent 2010;16:272-277.
Yun J, Adam J, Yerly D, et al. Human leukocyte antigens (HLA) associated drug hypersensitivity: consequences of drug binding to HLA. Allergy 2012;67:1338-1346.
Savard S, Desmeules S, Riopel J, et al. Linezolid-Associated acute interstitial nephritis and Drug Rash With Eosinophilia and Systemic Symptoms (DRESS) syndrome. Am J Kidney Dis 2009:54:17-20.
Kano Y, Ishida T, Hirahara K, et al. Visceral involvements and long-term sequelae in Drug-Induced Hypersensivitiy Syndrome. Med Clin N Am 2010;94:743-759.
Ushigome Y, Kano Y, Ishida T, et al. Short- and long-term outcomes of 34 patients with drug-induced hypersensitivity syndrome in a single institution. J Am Acad Dermatol 2012;10:1-8.
Husain Z, Reddy B, Schwartz R. DRESS syndrome. J Am Acad Dermatol 2013;68:709 e1-9.
Khan D, Solensky R, et al. Drug allergy. J Allergy Clin Immunol 2010;125:S126-S137.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2014 Revista Alergia México